Signadori Bio: Funding, Investors & Team (Aug 2026)
Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
Signadori Bio has raised $13.0M across 1 funding round on record, the most recent a Seed of $13.0M announced in May 2026.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Signadori Bio Company Profile and Key Stats
Latest funding round on record: May 2026.
Signadori Bio Funding Rounds
Signadori Bio Founders and Leadership Team
Contact details for the Signadori Bio team: 1 has a LinkedIn profile.
Start 14-day free trial →Signadori Bio Funding Compared to Other Health Care Startups
Signadori Bio's latest round of $13.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Signadori Bio in Health Care and Paris
Companies Similar to Signadori Bio
Beams is a producer of medical devices for cancerology based on the use of particles β.
Padoa is an occupational health software firm that develops a tool for monitoring the health of employees.…
CILcare specializes in providing drug solutions for hearing and ear disorders.
MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials,…
noa is a digital fitness and wellness company that offers premium, structured training programs for strength,…
Semeia offers patient monitoring solution designed to support medical followup of patients, remotely and in…
Axomove is an e-wellbeing application that spends significant time in video actual activities.
Parallel helps coding agent works side by side with hospital teams to deliver faster and more accurate…
May Health has created a new solution for infertility caused by Polycystic Ovary Syndrome (PCOS) that is…
MedinCell is an injectable slow-release drug specialist company.
Charles helps men regain control over their daily health concerns by starting with their personal health.
Lifeaz saves lives by developing a new generation of connected, simpler, more reliable and smarter…
Signadori Bio Funding FAQs
What does Signadori Bio do?
Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
How much funding has Signadori Bio raised?
Signadori Bio has raised $13.0M across 1 round on record. The most recent is a Seed of $13.0M announced in May 2026.
When did Signadori Bio last raise funding?
Signadori Bio's most recent funding round on record is a Seed of $13.0M, announced in May 2026.
Who founded Signadori Bio?
FundedIQ lists Selwyn Ho (Founder) at Signadori Bio.
Where is Signadori Bio headquartered?
Signadori Bio is based in Paris, Ile-de-France, France.
How many employees does Signadori Bio have?
Signadori Bio is in the 1-10 employee band.
How does Signadori Bio's funding compare to other Health Care startups?
Signadori Bio's latest round of $13.0M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Signadori Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Signadori Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.